All > Massachusetts Investigators

Whitney Howe

Massachusetts Eye and Ear Infirmary

Boston, Massachusetts - 02114 (617-573-4270)

CLINICAL TRIALS 2
CONDITIONS2
INTERVENTIONS3
SINCE2007

Topical Avastin for Treatment of Corneal Neovascularization

February 2007 - July 2010

Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

December 2009 - January 2012

Neovascularization, Pathologic

Corneal Neovascularization

Avastin (Bevacizumab)

Topical Bevacizumab

0.9% Nacl

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Whitney Howe

Massachusetts Eye and Ear Infirmary

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP